Teva Pharma (TEVA)

Company Ticker Sector | Industry Quality PAR
Teva Pharma TEVA Healthcare | Drugs (Specialty & Generic) 49 18.2%
Current Price (09/20) $7.45
CAPS Rating (Rate this stock on CAPS) Foolcaps 4
Expected Income Statement
Current Sales 17,771.8
Sales Growth Forecast 0.1%
Net Profit Margin 16.0%
Projected Shares Outstanding 1,116.67
EPS - Five year Forecast $2.56
Average P/E Ratio 6.7
Projected Average Price $17.20
Price Appreciation (Annualized) 18.2%
Annual Dividend Yield 0.0%
Projected Annual Return 18.2%
Quality
Financial Strength 71 17.7
EPS Stability 58 14.6
Industry Sales Growth Rate 9.5% 0.1
Industry Net Profit Margin 17.0% 11.8
Calculated Quality Rating 44.1
Fool CAPS

Total Players

2282 Outperforms
80 Underperforms
 

All-Stars (327)

319 Outperforms (98%)
8 Underperforms
 
Fundamental Data Updated: 07/12/2019

MIPAR 8.8%  
Sweet Spot 13.8% - 18.8%  

Top In Drugs (Specialty & Generic)

Ticker Quality PAR
SUPN 65 19.7%
TEVA 49 18.2%
PCRX 33 15.0%
CPIX 52 9.6%
ZTS 68 4.4%

Top In Healthcare

Ticker Quality PAR
ALGN 96 17.7%
JAZZ 94 16.7%
UNH 97 13.7%
ABBV 88 15.0%
BMY 93 23.9%